82 related articles for article (PubMed ID: 24697616)
1. Biomimetic design of platelet adhesion inhibitors to block integrin α2β1-collagen interactions: I. Construction of an affinity binding model.
Zhang L; Sun Y
Langmuir; 2014 Apr; 30(16):4725-33. PubMed ID: 24697616
[TBL] [Abstract][Full Text] [Related]
2. Biomimetic design of platelet adhesion inhibitors to block integrin α2β1-collagen interactions: II. Inhibitor library, screening, and experimental validation.
Zhang L; Zhang C; Sun Y
Langmuir; 2014 Apr; 30(16):4734-42. PubMed ID: 24697658
[TBL] [Abstract][Full Text] [Related]
3. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
Lecut C; Schoolmeester A; Kuijpers MJ; Broers JL; van Zandvoort MA; Vanhoorelbeke K; Deckmyn H; Jandrot-Perrus M; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1727-33. PubMed ID: 15231520
[TBL] [Abstract][Full Text] [Related]
4. Molecular underpinnings of integrin binding to collagen-mimetic peptides containing vascular Ehlers-Danlos syndrome-associated substitutions.
Hoop CL; Kemraj AP; Wang B; Gahlawat S; Godesky M; Zhu J; Warren HR; Case DA; Shreiber DI; Baum J
J Biol Chem; 2019 Sep; 294(39):14442-14453. PubMed ID: 31406019
[TBL] [Abstract][Full Text] [Related]
5. Arylamide derivatives as allosteric inhibitors of the integrin alpha2beta1/type I collagen interaction.
Yin H; Gerlach LO; Miller MW; Moore DT; Liu D; Vilaire G; Bennett JS; DeGrado WF
Bioorg Med Chem Lett; 2006 Jul; 16(13):3380-2. PubMed ID: 16678410
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent small molecule probe to modulate and explore α2β1 integrin function.
Koivunen JT; Nissinen L; Käpylä J; Jokinen J; Pihlavisto M; Marjamäki A; Heino J; Huuskonen J; Pentikäinen OT
J Am Chem Soc; 2011 Sep; 133(37):14558-61. PubMed ID: 21863823
[TBL] [Abstract][Full Text] [Related]
7. Involvement of activated integrin alpha2beta1 in the firm adhesion of platelets onto a surface of immobilized collagen under flow conditions.
Moroi M; Onitsuka I; Imaizumi T; Jung SM
Thromb Haemost; 2000 May; 83(5):769-76. PubMed ID: 10823276
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of the interactions between collagen and its receptors on platelets.
Deckmyn H; De Meyer SF; Broos K; Vanhoorelbeke K
Handb Exp Pharmacol; 2012; (210):311-37. PubMed ID: 22918737
[TBL] [Abstract][Full Text] [Related]
9. Adhesive domains in the collagen III fragment alpha1(III)CB4 that support alpha2beta1- and von Willebrand factor-mediated platelet adhesion under flow conditions.
Verkleij MW; IJsseldijk MJ; Heijnen-Snyder GJ; Huizinga EG; Morton LF; Knight CG; Sixma JJ; de Groot PG; Barnes MJ
Thromb Haemost; 1999 Sep; 82(3):1137-44. PubMed ID: 10494778
[TBL] [Abstract][Full Text] [Related]
10. Biomimetic Design of Peptide Neutralizer of Ebola Virus with Molecular Simulation.
Hou Q; Zhang L
Langmuir; 2020 Feb; 36(7):1813-1821. PubMed ID: 31986884
[TBL] [Abstract][Full Text] [Related]
11. Critical roles for the actin cytoskeleton and cdc42 in regulating platelet integrin alpha2beta1.
Pula G; Poole AW
Platelets; 2008 May; 19(3):199-210. PubMed ID: 18432521
[TBL] [Abstract][Full Text] [Related]
12. Biofunctionalization of a generic collagenous triple helix with the α2β1 integrin binding site allows molecular force measurements.
Niland S; Westerhausen C; Schneider SW; Eckes B; Schneider MF; Eble JA
Int J Biochem Cell Biol; 2011 May; 43(5):721-31. PubMed ID: 21262375
[TBL] [Abstract][Full Text] [Related]
13. Engineering integrin-specific surfaces with a triple-helical collagen-mimetic peptide.
Reyes CD; García AJ
J Biomed Mater Res A; 2003 Jun; 65(4):511-23. PubMed ID: 12761842
[TBL] [Abstract][Full Text] [Related]
14. A small-molecule inhibitor of integrin alpha2 beta1 introduces a new strategy for antithrombotic therapy.
Nissinen L; Pentikäinen OT; Jouppila A; Käpylä J; Ojala M; Nieminen J; Lipsanen A; Lappalainen H; Eckes B; Johnson MS; Lassila R; Marjamäki A; Heino J
Thromb Haemost; 2010 Feb; 103(2):387-97. PubMed ID: 20126829
[TBL] [Abstract][Full Text] [Related]
15. Integrin alpha2beta1 mediates the anti-angiogenic and anti-tumor activities of angiocidin, a novel tumor-associated protein.
Sabherwal Y; Rothman VL; Dimitrov S; L'Heureux DZ; Marcinkiewicz C; Sharma M; Tuszynski GP
Exp Cell Res; 2006 Aug; 312(13):2443-53. PubMed ID: 16762342
[TBL] [Abstract][Full Text] [Related]
16. Interactions of primary fibroblasts and keratinocytes with extracellular matrix proteins: contribution of alpha2beta1 integrin.
Zhang ZG; Bothe I; Hirche F; Zweers M; Gullberg D; Pfitzer G; Krieg T; Eckes B; Aumailley M
J Cell Sci; 2006 May; 119(Pt 9):1886-95. PubMed ID: 16636073
[TBL] [Abstract][Full Text] [Related]
17. Biomimetic design of affinity peptide ligand for capsomere of virus-like particle.
Li Y; Liu X; Dong X; Zhang L; Sun Y
Langmuir; 2014 Jul; 30(28):8500-8. PubMed ID: 24976378
[TBL] [Abstract][Full Text] [Related]
18. Determination of the ligand-binding specificities of the alpha2beta1 and alpha1beta1 integrins in a novel 3-dimensional in vitro model of pancreatic cancer.
Grzesiak JJ; Bouvet M
Pancreas; 2007 Mar; 34(2):220-8. PubMed ID: 17312461
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of the initial platelet adhesion in arterial thrombosis: molecular dynamics simulations.
Li J; Zhang L; Sun Y
J Mol Graph Model; 2012 Jul; 37():49-58. PubMed ID: 22622010
[TBL] [Abstract][Full Text] [Related]
20. Syndecan-1 supports integrin alpha2beta1-mediated adhesion to collagen.
Vuoriluoto K; Jokinen J; Kallio K; Salmivirta M; Heino J; Ivaska J
Exp Cell Res; 2008 Nov; 314(18):3369-81. PubMed ID: 18657535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
